Investors / XEIA Venture Partners
XEIA Venture Partners
Venture capital
XEIA Venture Partners is a venture firm that invests in early stage startups advancing what it calls Human 3, the next epoch of health, wellbeing and performance. It backs companies that combine life sciences, AI, hardware, software, deep tech and health tech, and says it helps portfolio companies with pharma partnerships, hiring and follow-on financing.
Invests inHealthcare & Biotech
In its own wordshealthtechneurotechailife sciencesmental healthdeep tech
Your fit with XEIA Venture Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsXEIA Venture Partners lists 18 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (90%), Robotics & Hardware (5%) and Industrial & Manufacturing (5%). 83% of its companies are based in United States. It invests most often alongside Jumpspace Ventures, Mystic Ventures and PsyMed Ventures.
No funding round on record names XEIA Venture Partners yet, so the figures come from its portfolio page.
Round figures show recent activity, not XEIA Venture Partners' whole history. Rounds on record name 0 companies; its own site lists 18. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 46th | 18 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 95th | 90% in its largest sector |
| Reach | 58th | 3 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers18100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 90% | 15% |
| Robotics & Hardware | 5% | 1% |
| Industrial & Manufacturing | 5% | 7% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Jumpspace Ventures
Compare XEIA Venture Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
18 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Aperture identifies naturally occurring gene variants that protect against neurodegeneration and designs oligonucleotide therapeutics mimicking their effect | Healthcare & Biotech | Portfolio page | ||
| Beond provides medically supervised ibogaine treatment for people living with PTSD, depression, anxiety, and chemical dependency | Healthcare & Biotech | Portfolio page | ||
| Biosphere is replacing the 1950's steam bioreactor with a modern, UV-enabled design that reduces the capital intensity of biomanufacturing. | Industrial & ManufacturingHealthcare & Biotech | Portfolio page | ||
| The company designs therapeutic neurotechnology to manage cancer from inside the body | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Freedom Biosciences is a biotechnology platform developing next-generation neuropsychiatric therapeutics. | Healthcare & Biotech | Portfolio page | ||
| Kadence Bio is a clinical-stage life sciences company developing novel therapeutics to address areas of significant unmet need in sexual and mental health. | Healthcare & Biotech | Portfolio page | ||
| Kerna Labs designs mRNA sequences for genetic medicine using AI and high-throughput biology | Healthcare & Biotech | Portfolio page | ||
| Mindstate Design Labs designs and develops psychoactive substances using molecular design and engineering techniques. | Healthcare & BiotechRobotics & Hardware | Portfolio page | ||
| Motif Neurotech builds neurotechnology to help monitor and regulate mental health and performance | Healthcare & Biotech | Portfolio page | ||
| NeuroBionics develops neural interfaces using bioelectronic fibers for neuromodulation therapies and research applications | Healthcare & Biotech | Portfolio page | ||
| Pangea Bio develops novel neuroplastic therapeutics to treat central nervous system disorders | Healthcare & Biotech | Portfolio page | ||
| Synchron builds implantable Brain-Computer Interfaces to protect what makes you human. | Healthcare & Biotech | Portfolio page | ||
| The company partners with employers to deliver an evidence-based mental health benefit for employees with treatment-resistant mental health conditions. | Healthcare & Biotech | Portfolio page | ||
| TippingPoint Biosciences develops drugs by studying chromatin assemblies and disease-specific conformations, rather than just proteins in isolation. | Healthcare & Biotech | Portfolio page | ||
| Ultra Bionics is developing implantable ultrasound technologies designed to expand what is possible in neuromodulation and neurological disease therapies. | Healthcare & Biotech | Portfolio page | ||
| Vonova develops minimally invasive transvascular technology to treat chronic neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Xylo is developing next-generation therapeutics designed to restore brain function | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- xeiavp.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 18
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get XEIA Venture Partners' profile as data
Pull XEIA Venture Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/xeiavp.com
# also
GET /v1/firms/xeiavp.com/portfolio
GET /v1/firms/xeiavp.com/coinvestors
GET /v1/firms/xeiavp.com/news